John Simon

As a Managing Director of General Catalyst Partners, John invests in both new and existing technology businesses. Areas of special interest include technology-intensive, industry-leading software and systems platforms; in particular: mission critical enterprise software applications and subsystems; software-based connectivity platforms with an emphasis on wireless; and software-based companies which sit at the intersection of media and technology. John is a board member of the following mission critical enterprise software applications and subsystems companies: GTESS; OutStart; and Vette. He also is a board member of connectivity platform companies, such as: BridgePort Networks; Hands-On Mobile; and JumpTap (General Catalyst co-founded the company). John is a board member of media/technology companies, such as: 80108 Media, BzzAgent, Maven Networks; and QuickPlay Media. He formerly served on the boards of: m-Qube, (General Catalyst co-founded the company) a General Catalyst investment that was acquired by Verisgn in May 2006; ProfitLogic, a General Catalyst investment that was acquired by Oracle in July 2005; and Taleo (NASDAQ: TLEO; f/k/a: Recruitsoft), which went public in September 2005.Prior to co-founding General Catalyst Partners, John was founder, Chairman and CEO of UroMed Corporation. UroMed completed its initial public offering in 1994 and was subsequently merged to form Alliant Medical Technologies. Prior to founding UroMed, John led marketing and sales at Adaptive Networks and was a venture capitalist with Highland Capital Partners and Charles River Ventures.John is a member of the Young Presidents’ Organization (YPO). He is a co-founder and current trustee of The Steppingstone Foundation, a non-profit organization that provides educational opportunities to deserving inner-city students. In addition to serving on the boards of Steppingstone and Steppingstone-Philadelphia, John has continued his involvement with the non-profit sector by founding the Green